MPM (drug)
Pharmaceutical compound
From Wikipedia, the free encyclopedia
MPM, also known as 2,5-dimethoxy-4-propoxyamphetamine or as TMA2-4-PrO, is a possible psychedelic drug of the phenethylamine, amphetamine, and DOx families.[1][2] It is a derivative of the DOx psychedelics TMA-2 and MEM in which the 4-position substituent has been extended.[1] The drug is also the α-methyl or amphetamine analogue of 2C-O-7.[1]
- None
| Clinical data | |
|---|---|
| Other names | 4-Propoxy-2,5-dimethoxyamphetamine; 2,5-Dimethoxy-4-propoxyamphetamine; TMA2-4-PrO |
| Routes of administration | Oral[1] |
| Drug class | Serotonin 5-HT2 receptor agonist |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | "Probably short"[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C14H23NO3 |
| Molar mass | 253.342 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Use and effects
In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists MPM's dose range as 30 mg or more orally and its duration as "probably short".[1] The drug produced weak or threshold effects at doses of 15 to 30 mg.[1][3] In another publication, Shulgin estimated an effective dose of MPM to be around 50 mg and the drug as being around half as potent as TMA-2 or MEM.[4]
Interactions
Pharmacology
Pharmacodynamics
MPM produces the head-twitch response, a behavioral proxy of psychedelic effects, in rodents.[5] It shows about the same potency as TMA-2 and MEM in this test.[5]
Chemistry
History
Society and culture
Legal status
Canada
MPM is a controlled substance in Canada under phenethylamine blanket-ban language.[6]